$12.97
0.806.57%
Last update: Nov 6, 6:22 PM
Kailera Therapeutics Inc
KLRANASDAQ
The average analyst price target for Kailera Therapeutics is $38, 185.5% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $30 to $48. The latest change came on May 12, 2026, when Leerink Partners initiated coverage of Kailera Therapeutics with an Outperform rating and a $36 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
